Similar Search Results

Quantifying gains in the war on cancer due to improved treatment and earlier detection

Seabury, Seth A.; Goldman, Dana P.; Gupta, Charu N.; … - In: Forum for health economics & policy : an evolving … 19 (2016) 1, pp. 14-139

Persistent link: https://www.econbiz.de/10011537383

A cost-benefit analysis of using evidence of effectiveness in terms of progression

Stevens, Warren; Philipson, Tomas J.; Wu, Yanyu; Chen, … - In: Forum for health economics & policy : an evolving … 17 (2014) 1, pp. 21-52

Persistent link: https://www.econbiz.de/10010413143

The contributions of improved therapy and earlier detection to cancer survival gains, 1988 - 2000

Sun, Eric; Jena, Anupam B.; Lakdawalla, Darius; Reyes, … - In: Forum for health economics & policy : an evolving … 13 (2010) 2, pp. 1-20

Persistent link: https://www.econbiz.de/10009616663

Effects of expanding health screening on treatment : what should we expect? ; what can we learn?

Myerson, Rebecca Mary; Lakdawalla, Darius; Colantonio, … - 2018

Persistent link: https://www.econbiz.de/10011813027

Does Medicare coverage improve cancer detection and mortality outcomes?

Myerson, Rebecca Mary; Tucker-Seeley, Reginald; … - 2019

Persistent link: https://www.econbiz.de/10012121070

Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?

Myerson, Rebecca; Tucker-Seeley, Reginald; Goldman, Dana; … - 2020

cancer. We used a regression discontinuity design to assess impacts of near‐universal Medicare insurance at age 65 on cancer … detection and outcomes, using population‐based cancer registries and vital statistics data. Our analysis focused on the three … tumor sites for which screening is recommended both before and after age 65: breast, colorectal, and lung cancer. At age 65 …

Persistent link: https://www.econbiz.de/10014102325

Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data

Michaud, Pierre-Carl; Lakdawalla, Darius; Goldman, Dana; … - Centre Interuniversitaire sur le Risque, les Politiques … - 2010

We propose to combine clinical trial and estimates of behavioral responses in the population to quantify the value of new drug innovations when such values cannot be obtained by randomized experiments alone. New drugs are seen as having two distinct effects on patients. First, they can provide...

Persistent link: https://www.econbiz.de/10008646239